Research ArticleCancer

JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors

See allHide authors and affiliations

Science Signaling  29 Mar 2016:
Vol. 9, Issue 421, pp. ra33
DOI: 10.1126/scisignal.aac8460

Article Information

vol. 9 no. 421 ra33

PubMed: 
Published By: 
Print ISSN: 
Online ISSN: 
History: 
  • Received July 6, 2015
  • Accepted March 8, 2016
  • .

Author Information

Altmetric

Article usage

Article usage: March 2016 to September 2019

AbstractFullPdf
Mar 20162151126265
Apr 20162649173328
May 20163465196
Jun 20163263585
Jul 20162162344
Aug 20161551026
Sep 20161441028
Oct 20162411739
Nov 20162311122
Dec 2016180819
Jan 20171451232
Feb 2017111916
Mar 2017113419
Apr 201790021
May 201794614
Jun 20176516
Jul 201780211
Aug 201785816
Sep 20178259
Oct 201778710
Nov 201796317
Dec 20174929
Jan 20187838
Feb 201885516
Mar 20181023144
Apr 2018572721
May 2018782543
Jun 2018582826
Jul 2018382021
Aug 201808820
Sep 201809726
Oct 201805521
Nov 201806323
Dec 201808626
Jan 201946921
Feb 201985221
Mar 201957331
Apr 201925416
May 201974533
Jun 201955121
Jul 201984030
Aug 201974724
Sep 20192277

Navigate This Article